文献速递重症综合管理与镇静镇痛心脑血管急症

神经危重症患者的谵妄监测:系统评价

Delirium Monitoring in Neurocritically Ill Patients: A Systematic Review.
PubMed 文献 · Crit Care Med · 2018-01-01
一句话结论神经危重症患者谵妄汇总患病率12-43%,经验证工具与DSM-IV对照敏感性62-76%、特异性74-98%,谵妄与住院时间延长和功能独立、认知结局较差相关,但与生存无关。

本系统评价检索了CINAHL、Web of Science和PubMed,纳入7项前瞻性队列研究共1173例神经危重症患者(如神经创伤、缺血性或出血性卒中),评估经验证的谵妄工具在此类患者中的表现及谵妄与临床结局的关联。汇总谵妄患病率为12-43%;与DSM-IV参考标准比较,敏感性62-76%、特异性74-98%、阳性预测值63-91%、阴性预测值70-94%、评定者间信度kappa 0.64-0.94。4项多变量分析研究中,谵妄与住院时间延长(3项)、ICU住院时间延长(1项)、功能独立较差(1项)和认知较差(2项)相关,但与生存无关。结论提示原发性神经疾病患者可符合谵妄诊断标准,谵妄特征可能预测不良临床结局,但该人群谵妄监测仍需进一步研究。

要点

  • 神经危重症患者(神经创伤、缺血性或出血性卒中)谵妄汇总患病率为12-43%。
  • 经验证谵妄工具与DSM-IV对照:敏感性62-76%、特异性74-98%、阳性预测值63-91%、阴性预测值70-94%。
  • 评定者间信度kappa为0.64-0.94。
  • 谵妄与住院时间延长(3项研究)、ICU住院时间延长(1项)、功能独立较差(1项)和认知较差(2项)相关,但与生存无关。
  • 重症医学会(Society of Critical Care Medicine)推荐常规谵妄监测,该推荐基于无原发性神经损伤的危重症患者数据。

适用人群与场景

  • 神经危重症患者,包括神经创伤、缺血性和/或出血性卒中,任何年龄。
  • 纳入标准允许任何研究设计调查神经危重症患者的谵妄监测。

诊断标准与关键阈值

  • 以《精神障碍诊断与统计手册》第四版(DSM-IV)作为共同参考标准评估谵妄工具的诊断性能。

研究设计与关键结果

  • 研究类型:系统评价,纳入7项前瞻性队列研究,共1173例神经危重症患者。
  • 汇总谵妄患病率为12-43%。
  • 与DSM-IV对照,谵妄工具敏感性62-76%、特异性74-98%、阳性预测值63-91%、阴性预测值70-94%、评定者间信度kappa 0.64-0.94。
  • 4项报告多变量分析的研究中,谵妄与住院时间延长(3项研究)、ICU住院时间延长(1项研究)、功能独立较差(1项研究)和认知较差(2项研究)相关,但与生存无关。

证据类型、等级与局限

  • 证据类型:系统评价,纳入7项前瞻性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 重症医学会(Society of Critical Care Medicine)推荐常规谵妄监测,但该推荐基于无原发性神经损伤的危重症患者数据;本系统评价显示神经危重症患者也可符合谵妄诊断标准,且谵妄特征可能预测不良临床结局。
  • 作者认为需要针对这类复杂神经危重症患者的谵妄开展持续研究。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: The Society of Critical Care Medicine recommends routine delirium monitoring, based on data in critically ill patients without primary neurologic injury. We sought to answer whether there are valid and reliable tools to monitor delirium in neurocritically ill patients and whether delirium is associated with relevant clinical outcomes (e.g., survival, length of stay, functional independence, cognition) in this population.

DATA SOURCES: We systematically reviewed Cumulative Index to Nursing and Allied Health Literature, Web of Science, and PubMed.

STUDY SELECTION AND DATA EXTRACTION: Inclusion criteria allowed any study design investigating delirium monitoring in neurocritically ill patients (e.g., neurotrauma, ischemic, and/or hemorrhagic stroke) of any age. We extracted data relevant to delirium tool sensitivity, specificity, negative predictive value, positive predictive value, interrater reliability, and associated clinical outcomes.

DATA SYNTHESIS: Among seven prospective cohort studies and a total of 1,173 patients, delirium was assessed in neurocritically patients using validated delirium tools after considering primary neurologic diagnoses and associated complications, finding a pooled prevalence rate of 12-43%. When able to compare against a common reference standard, Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, the test characteristics showed a sensitivity of 62-76%, specificity of 74-98%, positive predictive value of 63-91%, negative predictive value of 70-94%, and reliability kappa of 0.64-0.94. Among four studies reporting multivariable analyses, delirium in neurocritically patients was associated with increased hospital length of stay (n = 3) and ICU length of stay (n = 1), as well as worse functional independence (n = 1) and cognition (n = 2), but not survival.

CONCLUSIONS: These data from studies of neurocritically ill patients demonstrate that patients with primary neurologic diagnoses can meet diagnostic criteria for delirium and that delirious features may predict relevant untoward clinical outcomes. There is a need for ongoing investigations regarding delirium in these complicated neurocritically ill patients.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Patel MB, Bednarik J, Lee P, et al. Delirium Monitoring in Neurocritically Ill Patients: A Systematic Review. Crit Care Med. 2018. PMID: 30142098. doi:10.1097/CCM.0000000000003349

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。